Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma, Capillary 2Weight Loss 1Spinal Cord Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hemangioma 1Cachexia 1

Interventions

Timolol 7Propranolol 7Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Surgery, Computer-Assisted 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemangioma, Capillary × Atenolol × Clear all
NCT02342275 2022-06-16

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma

West China Hospital

Phase 3 Completed
377 enrolled 13 charts

Hemangioma, Hemangioma, Capillary

NCT03237637 2018-08-28

Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
60 enrolled

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡